Mubasher Philadelphia Pharmaceuticals Company reported on Thursday net profit of JOD 2.7 million in 2015, a fall of 10.56% compared to JOD 3.02 million in 2014, according to the company’s financial statements.
The Amman-listed company earlier posted a net profit of JOD 2.54 million in the first nine months of 2015, versus JOD 2.52 million in 2014.
